| 000 | 01249 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515112753.0 | ||
| 264 | 0 | _c20080716 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1476-5470 | ||
| 024 | 7 |
_a10.1038/gene.2008.9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorm, M E A | |
| 245 | 0 | 0 |
_aThe effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype. _h[electronic resource] |
| 260 |
_bGenes and immunity _cApr 2008 |
||
| 300 |
_a274-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAcetylmuramyl-Alanyl-Isoglutamine _xpharmacology |
| 650 | 0 | 4 |
_aCrohn Disease _xgenetics |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMonocytes _xmetabolism |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aNod2 Signaling Adaptor Protein _xgenetics |
| 650 | 0 | 4 |
_aToll-Like Receptor 2 _xmetabolism |
| 700 | 1 | _avan Bodegraven, A A | |
| 700 | 1 | _aMulder, C J J | |
| 700 | 1 | _aKraal, G | |
| 700 | 1 | _aBouma, G | |
| 773 | 0 |
_tGenes and immunity _gvol. 9 _gno. 3 _gp. 274-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/gene.2008.9 _zAvailable from publisher's website |
| 999 |
_c17842037 _d17842037 |
||